Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...